Poster presented at The Liver Meeting, organized by the American Association for the Study of Liver Diseases, Nov 13-16, 2020 – Virtual experience
Based on a meta-analysis, the poster analyses radiomics contribution to liver cancer recurrence prediction and shows how radiomics are approaching their limits for predicting disease outcome. Imaging phenomics, an emerging technology implemented in Median’s iBiopsy® platform may provide the framework to explore new associations between phenotypes which are currently not feasible using traditional radiomic workflows.